Delivery Order HHSN261201000021I-HHSN26100001
Award Date 4/21/10
Potential Completion Date 9/30/14
Potential Value $24K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94103, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $161,250 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The Johns Hopkins University (JHU) for the Cancer Genome Atlas (TCGA) program. The order is part of a larger NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The work involves providing tissue samples and data from various cancer types to support the TCGA, a collaborative effort to accelerate the understanding of the molecular basis of cancer through the application of genome...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Duke University for $270,900.00. The contract is part of the NCI's Cancer Genome Atlas (TCGA) program and is funded through the American Recovery and Reinvestment Act (ARRA). Under this contract, Duke University will provide tissue samples and data from various types of cancer to support the TCGA program. The contract does not have a...
- This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
- This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...
- This is a $33,756 firm-fixed-price delivery order issued under the National Cancer Institute's Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract. The order was awarded to The Vanderbilt University, a leading private research institution, to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The award is funded through the American Recovery and Reinvestment Act (ARRA) and has an ultimate completion date of September...
- This is a $530,233.58 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services, to the University of Pittsburgh. The contract supports the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA), which aims to collect tissue samples and data from various cancer types. The contract does not have a set-aside designation. The University of Pittsburgh, a large...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...
- This is a $142,143.34 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the University of Pittsburgh for the NCI's Cancer Genome Atlas (TCGA) program. The contract is to provide tissue samples and data from various types of cancer to support the TCGA program, which aims to construct a comprehensive "atlas" of the molecular changes involved in human cancers. The award is not set aside and is part of a larger IDIQ contract titled the "NCI Cancer...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer, a non-profit organization and foundation in Spain. The $6,000 contract is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is a joint effort between the National...
- HHSN261201000021IIndefinite Delivery Contract
- HHSN261201000021I-HHSN26100001Delivery Order
This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Regents of the University of California, San Francisco (UCSF) for the Cancer Genome Atlas (TCGA) program. The contract, valued at $24,087.50, is for the acquisition of tissue samples and data from various types of cancer to support the TCGA program, which is part of the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation and is a firm fixed-price type. UCSF, as a leading academic medical center and research institution, has a strong track record of partnering with federal agencies like NCI to conduct cutting-edge biomedical research and deliver healthcare innovations.
Generated 4/3/25, 10:27 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program | RFQ-NCI-10006-AS | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 12/4/09, 8:31 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 3 | Other Administrative Action | ($9k) | 12/29/14 | |
| 2 | Other Administrative Action | $0 | 10/27/11 | |
| 1 | Funding Only Action | $23.1k | 9/3/10 | |
| Not listed | Not listed | $10.3k | 4/21/10 |